Endothelin Receptor Antagonist Ambrisentan, SGLT2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy
DOI: 10.1681/asn.0000001097Author: Qinlan Chen et al.Published: 2026-4-8

Forum › Forums › Available Download: › DOI › Endothelin Receptor Antagonist Ambrisentan, SGLT2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy

DOI: 10.1681/asn.0000001097Author: Qinlan Chen et al.Published: 2026-4-8

Tagged: 

  • This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • April 12, 2026 at 8:38 pm #906
    wesleyWesley
    Participant

    Title: Endothelin Receptor Antagonist Ambrisentan, SGLT2 Inhibitor Henagliflozin, and Their Combination in IgA Nephropathy
    Journal: Journal of the American Society of Nephrology
    Authors: Qinlan Chen, Pei Chen, Lijun Liu, Sufang Shi, Xujie Zhou, Hongyu Yang, Yang Li, Ling Guo, Sainan Zhu, Jinwei Wang, Yunfei Bao, Qiong Zhang, Muqing Liu, Xiaoyuan Ning, Yuting Cai, Rong He, Yanjie Liu, Qian Wang, Jicheng Lv, Hong Zhang
    Date: 2026-4-8
    DOI: 10.1681/asn.0000001097
    Source: Ovid Technologies (Wolters Kluwer Health)
    Source URL: https://doi.org/10.1681/asn.0000001097

  • Author
    Posts
Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.